Quarterly report · Q2
7129.TEDINET S100S68R
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥22.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥25m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥7m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥20m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥169m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥11m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥40m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥54m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥810m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥676m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥144m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥557m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥103m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥621m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥369m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥446m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-13.06 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.8 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.83 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 24.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥452m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥431m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥383m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥243m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥86m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥245m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥408m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥443m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥430m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥393m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥240m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥61m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥204m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥383m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥400m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 549
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts payable other | Prior1YearInstant | 287113000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 364313000 | JPY |
| Accrued expenses | Prior1YearInstant | 558886000 | JPY |
| Accrued expenses | CurrentQuarterInstant | 690273000 | JPY |
| Income taxes payable | Prior1YearInstant | 59659000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 27375000 | JPY |
| Deposits received | Prior1YearInstant | 81696000 | JPY |
| Deposits received | CurrentQuarterInstant | 125852000 | JPY |
| Contract liabilities | Prior1YearInstant | 12805000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 81450000 | JPY |
| Asset retirement obligations cl | Prior1YearInstant | 55234000 | JPY |
| Asset retirement obligations cl | CurrentQuarterInstant | - | JPY |
| Provision for bonuses | Prior1YearInstant | 367002000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 376021000 | JPY |
| Provision for loss on business closure cl | Prior1YearInstant | 4461000 | JPY |
| Provision for loss on business closure cl | CurrentQuarterInstant | - | JPY |
| Other cl | Prior1YearInstant | 33436000 | JPY |
| Other cl | CurrentQuarterInstant | 18001000 | JPY |
| Current liabilities | Prior1YearInstant | 6583046000 | JPY |
| Current liabilities | CurrentQuarterInstant | 6255151000 | JPY |
| Bonds payable | Prior1YearInstant | 34500000 | JPY |
| Bonds payable | CurrentQuarterInstant | 24000000 | JPY |
| Long term loans payable | Prior1YearInstant | 1876848000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 1747370000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 295129000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 278716000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 740597000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 709991000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 1028594000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 1015542000 | JPY |
| Other ncl | Prior1YearInstant | 239463000 | JPY |
| Other ncl | CurrentQuarterInstant | 195003000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 4215132000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 3970624000 | JPY |
| Liabilities | Prior1YearInstant | 10798179000 | JPY |
| Liabilities | CurrentQuarterInstant | 10225775000 | JPY |
| Capital stock | Prior1YearInstant | 300620000 | JPY |
| Capital stock | CurrentQuarterInstant | 306156000 | JPY |
| Capital surplus | Prior1YearInstant | 517621000 | JPY |
| Capital surplus | CurrentQuarterInstant | 523157000 | JPY |
| Retained earnings | Prior1YearInstant | 2519493000 | JPY |
| Retained earnings | CurrentQuarterInstant | 2444671000 | JPY |
| Treasury stock | Prior1YearInstant | -100000 | JPY |
| Treasury stock | CurrentQuarterInstant | -100000 | JPY |
| Shareholders equity | Prior1YearInstant | 3337635000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 3273885000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 96000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 128000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 96000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 128000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |